Credit: Endo, Inc At this time, there have been no reports of adverse events related to this recall. While the blister strips ...

Icotrokinra, formerly known as JNJ-2113, is an investigational oral peptide that blocks the interleukin (IL)-23 receptor, which plays a significant role in the pathogenesis of moderate to severe ...

The phase 3 trial met both primary pharmacokinetic endpoints. Topline results were announced from a phase 3 trial investigating a subcutaneous formulation of pembrolizumab, a programmed death receptor ...

From 2022 to 2023, there was a 20 percent increase in estimated measles cases worldwide, from 8,645,000 to 10,341,000 ...

“The results of this cohort study suggest that metformin was associated with a lower rate of asthma attacks, with further reductions with the use of GLP-1 RA,” the authors write. “This appeared to be ...

The researchers found that 10.4% were dispensed a gabapentinoid before hip fracture. There was an increased risk for hip fracture with gabapentinoid dispensing (odds ratio, 1.96). The odds of hip ...

The researchers found that most issues that patients initiated in discussion were omitted from notes. (HealthDay News) — Physician electronic health record (EHR) notes of primary care patient ...

Tryvio TM (aprocitentan) is now available for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure (BP) in adult patients who are not adequately ...

PreHevbrio was approved for the prevention of infection caused by all subtypes of hepatitis B virus in adults aged 18 years and older.

Supplementation with cholecalciferol during pregnancy linked to increased bone mineral content, bone mineral density, lean mass in offspring ...

A Prescription Drug User Fee Act date of April 2, 2025 has been assigned to the resubmitted application. The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug ...

The Company is seeking approval of tirzepatide for the treatment of HFpEF and obesity and has submitted data to the FDA. Detailed results were announced from a phase 3 clinical trial evaluating the ...